Bharat Biotech, CSIR collaborate to make raw material for vaccines

India now imports adjuvants and other chemicals for vaccine manufacturing

In an attempt to make India self-reliant in manufacturing raw material for vaccines like adjuvants (which enhance the immune system) and other chemicals, Hyderabad-based Bharat Biotech has tied up with the Council of Scientific and Industrial Research (CSIR) to work on technologies and platforms for novel vaccines, drugs, and even raw materials.
 
On Monday, Bharat Biotech International, Biovet, and Sapigen Biologix signed a joint Master Collaborative Agreement (MCA) with CSIR-Indian Institute of Chemical Technology (CSIR-IICT) to work on developing novel platform technologies for bio-therapeutics and vaccines to support indigenous, affordable health care solutions for humans and animals.
 
The